Companies House does not verify the accuracy of the information filed(link opens a new window)
Advanced company searchLink opens in new window

NERRE THERAPEUTICS HOLDINGS LIMITED

Company number 10753026

Follow this company File for this company
Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
09 Jul 2021 SH01 Statement of capital following an allotment of shares on 25 June 2021
  • GBP 3,413.387855
07 Jul 2021 AA Accounts for a small company made up to 30 June 2020
30 Jun 2021 AP01 Appointment of Mr Javier García Cogorro as a director on 25 June 2021
30 Jun 2021 PSC07 Cessation of Advent Life Sciences Llp as a person with significant control on 25 June 2021
05 May 2021 CS01 Confirmation statement made on 2 May 2021 with no updates
20 Nov 2020 MA Memorandum and Articles of Association
20 Nov 2020 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES01 ‐ Resolution of adoption of Articles of Association
04 May 2020 CS01 Confirmation statement made on 2 May 2020 with updates
18 Mar 2020 AA Full accounts made up to 30 June 2019
01 Nov 2019 SH10 Particulars of variation of rights attached to shares
01 Nov 2019 SH08 Change of share class name or designation
08 May 2019 CS01 Confirmation statement made on 2 May 2019 with updates
15 Feb 2019 SH01 Statement of capital following an allotment of shares on 29 January 2019
  • GBP 1,813.2943
05 Feb 2019 AA Full accounts made up to 30 June 2018
30 Nov 2018 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES09 ‐ Resolution of authority to purchase a number of shares
  • RES01 ‐ Resolution of adoption of Articles of Association
30 Nov 2018 SH01 Statement of capital following an allotment of shares on 23 November 2018
  • GBP 1,806.92930
30 Nov 2018 SH06 Cancellation of shares. Statement of capital on 23 November 2018
  • GBP 1,806.93
30 Nov 2018 SH03 Purchase of own shares.
22 May 2018 CS01 Confirmation statement made on 2 May 2018 with updates
22 May 2018 PSC02 Notification of Advent Life Sciences Llp as a person with significant control on 8 September 2017
20 Mar 2018 SH01 Statement of capital following an allotment of shares on 15 March 2018
  • GBP 1,392.34955
24 Jan 2018 SH01 Statement of capital following an allotment of shares on 22 January 2018
  • GBP 1,392.22455
12 Dec 2017 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association
16 Nov 2017 AP01 Appointment of Mr Andrew Kay as a director on 15 September 2017
25 Oct 2017 SH02 Sub-division of shares on 8 September 2017